UPDATED Apr 22, 2024
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
FAR | CA$3.16 | -1.9% | 66.3% | CA$312.1m | CA$5.13 | PE7.9x | E26.7% | 1.9% | Materials | ||
IQ | CA$0.42 | -3.4% | 52.7% | CA$12.4m | n/a | PE3.4x | n/a | n/a | Software | ||
FSZ | CA$7.60 | 2.4% | 2.8% | CA$786.6m | CA$7.79 | PE13.8x | E-1.8% | 11.3% | Diversified Financials | ||
SIL | CA$10.69 | 10.9% | 17.6% | CA$1.5b | CA$10.11 | PE9.8x | E-31.2% | n/a | Materials | ||
POE | CA$1.21 | 0.8% | 31.5% | CA$60.3m | CA$1.35 | PE3.9x | n/a | n/a | Energy | ||
PRL | CA$23.37 | 6.5% | 249.9% | CA$737.4m | CA$24.37 | PE21.1x | E33.6% | 2.0% | Diversified Financials | ||
SOMA | CA$0.58 | 0% | -3.3% | CA$52.1m | n/a | PE9x | n/a | n/a | Materials | ||
CNO | CA$0.38 | -10.6% | 230.4% | CA$16.8m | n/a | PE16.3x | n/a | n/a | Capital Goods | ||
GSY | CA$175.09 | 7.1% | 93.6% | CA$2.9b | CA$206.11 | PE11.8x | E14.1% | 2.7% | Diversified Financials | ||
CTH | CA$0.50 | 0% | -9.1% | CA$29.2m | n/a | PE2.4x | n/a | n/a | Energy | ||
HPS.A | CA$133.27 | -14.4% | 255.4% | CA$1.5b | CA$162.33 | PE25x | E-0.8% | 0.5% | Capital Goods | ||
DOL | CA$113.61 | 1.8% | 34.5% | CA$31.8b | CA$115.75 | PE31.3x | E8.6% | 0.3% | Retail | ||
CANB | CA$0.085 | 0% | -57.5% | CA$11.8m | n/a | PE3.6x | n/a | n/a | Pharmaceuticals & Biotech | ||
CGD | CA$0.16 | -11.1% | -20.0% | CA$3.0m | n/a | PE2.9x | n/a | n/a | Materials | ||
FW | CA$0.50 | -5.7% | -13.8% | CA$15.7m | n/a | PE1.6x | n/a | 0% | Diversified Financials | ||
MGZ.H | CA$0.035 | 0% | -50.0% | CA$45.1m | n/a | PE0.9x | n/a | n/a | Materials | ||
CURE | CA$0.015 | 0% | 50.0% | CA$1.4m | n/a | PE0.6x | n/a | n/a | Pharmaceuticals & Biotech |